acsbiomaterials.0c00197.pdf (1.01 MB)
Graphene-induced transdifferentiation of cancer stem cells as a therapeutic strategy against glioblastoma
journal contribution
posted on 2023-06-07, 07:00 authored by Costanza Martelli, Alice KingAlice King, Thomas Simon, Georgios GiamasGeorgios GiamasGlioblastoma (GBM) is an extremely malignant tumor of the central nervous system, characterized by low response to treatments and reoccurrence. This therapeutic resistance is believed to arise mostly from the presence of a subpopulation of tumorigenic stem cells, known as cancer stem cells (CSCs). In addition, the surrounding microenvironment is known to maintain CSCs, thus supporting tumor development and aggressiveness. This review focuses on a therapeutic strategy involving the stem cell trans-differentiating ability of graphene and its derivatives. Graphene distinguishes itself from other carbon-based nanomaterials due to an array of properties that makes it suitable for many purposes, from bioengineering to biomedical applications. Studies have shown that graphene is able to promote and direct the differentiation of CSCs. In addition, potential usage of graphene in GBM treatment represents a challenge in respect to its administration method. The present review also provides a general outlook of the potential side effects (e.g., cell toxicity) that graphene could have. Overall, this report discusses certain graphene-based therapeutic strategies targeting CSCs, which can be considered as prospective effective GBM treatments.
History
Publication status
- Published
File Version
- Accepted version
Journal
ACS Biomaterials Science & EngineeringISSN
2373-9878Publisher
American Chemical SocietyExternal DOI
Department affiliated with
- Biochemistry Publications
Full text available
- Yes
Peer reviewed?
- Yes
Legacy Posted Date
2020-05-15First Open Access (FOA) Date
2021-04-21First Compliant Deposit (FCD) Date
2020-05-15Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC